Serial 87052324

Dead / Cancelled — Cancelled — Section 8 (as of 28 May 2024)

What this means for you

This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
87052324
Registration number
5332632
Mark type
Design / logo
Filed
27 May 2016
Published for opposition
29 Aug 2017
Registered
14 Nov 2017
Attorney of record
Mark Harrison

Goods and services

  • Class 001 — Chemicals: Chemicals for use in industry and science; chemicals test kits for in vitro testing for laboratory research purposes; biochemicals, namely, monoclonal antibodies and antibody fragments all being proteins for in vitro scientific and laboratory research use; biochemicals, namely, monoclonal antibodies and antibody fragments all being proteins for scientific and laboratory research use; biochemical, namely, monoclonal antibodies and antibody fragments all being protein in raw material form for scientific research purposes; antibody reagents used for the detection of antigens in cell and tissue analysis for scientific and laboratory in vitro diagnostic use; antibodies and antibody fragments all being proteins for industrial use in the discovery, preclinical and clinical development of therapeutic products
  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders and dermatological diseases; veterinary preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders and dermatological diseases; therapeutic pharmaceutical preparations in the nature of antibodies and antibody fragments for medical and veterinary purposes; antibodies being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders and dermatological diseases; antibody fragments being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ and tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders and dermatological diseases; monoclonal antibody therapeutic preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ and tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders and dermatological diseases; antibodies and antibody fragments being diagnostic reagents for medical and veterinary diagnostics; antibodies and antibody fragments for use in the discovery, preclinical and clinical development of therapeutic products; antibodies and antibody fragments being therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ and tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders and dermatological diseases for use in the manufacture of therapeutic products
  • Class 031 — Natural agricultural products: Live animals; live mice
  • Class 040 — Treatment of materials: Treatment and transformation of materials for others, namely, the manufacture of chemicals, biologicals, antibodies and antibody fragments; contract manufacturing services in the field of chemicals, biologicals, antibodies and antibody fragments; custom manufacture of therapies using antibodies and antibody fragments
  • Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research, analysis and testing, and research and design in the field of therapeutic pharmaceuticals; scientific laboratory services; laboratory services in the field of antibodies and antibody fragments; research in the field of the development of antibodies and antibody fragments; provision of scientific information in the field of antibodies and antibody fragments for medical and veterinary purposes; engineering of antibodies and antibody fragments; scientific services, namely, the discovery, preclinical and clinical development of therapeutic products; consultancy services relating thereto, namely, therapeutic products

Owner

Prosecution history

  • 28 May 2024 — CANCELLED SEC. 8 (6-YR)
  • 14 Nov 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 14 Nov 2017 — REGISTERED-PRINCIPAL REGISTER
  • 29 Aug 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 29 Aug 2017 — PUBLISHED FOR OPPOSITION
  • 09 Aug 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 26 Jul 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 19 Jul 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 18 Jul 2017 — ASSIGNED TO LIE
  • 09 Jun 2017 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
  • 28 Apr 2017 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
  • 28 Apr 2017 — INQUIRY TO SUSPENSION E-MAILED
  • 28 Apr 2017 — SUSPENSION INQUIRY WRITTEN
  • 28 Oct 2016 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
  • 28 Oct 2016 — LETTER OF SUSPENSION E-MAILED

View this trademark record on Marksy